Status report
Get it in writing
The official USPTO status record for CLAIMEL, serial 85230067, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
CLAIMELSerial 85230067 · Principal Register
Dead · Refused
Owner: Glaxo Group Limited
Class 005 - Pharmaceuticals
Filed Jan 31, 2011
The record shows that CLAIMEL is an abandoned application – the USPTO marked it “dead” after no Statement of Use was filed, with the abandonment notice dated September 8 2014 – and the owner listed is Glaxo Group Limited, a corporation organized in the United Kingdom. The filing covered only International Class 005, specifically “pharmaceutical preparations and substances” for a very wide range of medical conditions and vaccines, so a later use of the same word in the pharmaceutical field would be the closest record‑based concern. The record does not give Glaxo control over every possible use of the word CLAIMEL in other industries or contexts. Because the application was on the Principal Register and never reached registration, there is no supplemental‑register sequence to note. The latest meaningful event is the abandonment notice; no oppositions, cancellations or court actions appear in the history. I'd treat this as a modest concern if you plan a pharma‑related brand, but the risk drops sharply outside that sector.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.